New licensing agreements signal industry-wide recognition that on-site enzymatic DNA synthesis is now essential infrastructure for closed-loop AI drug discovery
Adjusting temperature and calcium levels in early laboratory evaluations reveals hidden drug behaviors that may be missed under standard testing conditions
From GPCR binding panels to cell viability and reporter gene combinations, multiplex microplate assays are reshaping how preclinical drug discovery teams screen compound libraries